Preface to the first edition |
|
v | |
Acknowledgements |
|
vi | |
Preface to the second edition |
|
vii | |
|
|
1 | (5) |
|
Basic types of economic evaluation |
|
|
6 | (21) |
|
Why is economic evaluation important? |
|
|
7 | (1) |
|
What does economic evaluation mean? |
|
|
8 | (3) |
|
Do all economic evaluations use the same techniques? |
|
|
11 | (6) |
|
What are the relevant costs and consequences in the economic evaluation of health care programmes? |
|
|
17 | (10) |
|
Critical assessment of economic evaluation |
|
|
27 | (25) |
|
Elements of a sound economic evaluation |
|
|
29 | (15) |
|
Limitations of economic evaluation techniques |
|
|
44 | (1) |
|
|
45 | (1) |
|
Critical appraisal of a published article |
|
|
45 | (7) |
|
|
52 | (44) |
|
|
52 | (16) |
|
Allowance for differential timing of costs (discounting and the annuitization of capital expenditures) |
|
|
68 | (6) |
|
Allocation of overhead costs: example |
|
|
74 | (7) |
|
Exercise: costing alternative radiotherapy treatments |
|
|
81 | (15) |
|
Annex 4.1. Tutorial on methods of measuring and valuing capital costs |
|
|
88 | (4) |
|
Annex 4.2. Discount Tables |
|
|
92 | (4) |
|
Cost-effectiveness analysis |
|
|
96 | (43) |
|
|
96 | (16) |
|
Exercise: designing a cost-effectiveness study |
|
|
112 | (12) |
|
Critical appraisal of a published article |
|
|
124 | (4) |
|
Use of quality-of-life scales in economic evaluation |
|
|
128 | (3) |
|
Interpreting incremental cost-effectiveness ratios |
|
|
131 | (8) |
|
|
139 | (66) |
|
|
139 | (4) |
|
|
143 | (7) |
|
|
150 | (7) |
|
Multi-attribute health status classification systems with preference scores |
|
|
157 | (8) |
|
Quality-adjusted life-years (QALYs) |
|
|
165 | (18) |
|
|
183 | (2) |
|
Critical appraisal of a published article |
|
|
185 | (20) |
|
Annex 6.1. Simulated interview |
|
|
199 | (6) |
|
|
205 | (27) |
|
|
205 | (3) |
|
Assigning money values to health outcomes |
|
|
208 | (9) |
|
What might we mean by willingness-to-pay? |
|
|
217 | (5) |
|
Pragmatic measurement issues |
|
|
222 | (3) |
|
|
225 | (1) |
|
Exercise: designing a contingent valuation survey for a new treatment for ovarian cancer |
|
|
225 | (7) |
|
Collection and analysis of data |
|
|
232 | (33) |
|
|
232 | (3) |
|
Economic evaluation and clinical trials |
|
|
235 | (7) |
|
Modelling studies: approaches and issues |
|
|
242 | (5) |
|
Analysis plans for economic evaluation |
|
|
247 | (1) |
|
Statistical analysis and economic evaluation |
|
|
248 | (8) |
|
|
256 | (1) |
|
|
257 | (1) |
|
Exercise: economic evaluation alongside clinical trials - a case study in osteoporosis |
|
|
258 | (7) |
|
Presentation and use of economic evaluation results |
|
|
265 | (28) |
|
|
265 | (1) |
|
Reporting formats for economic evaluation |
|
|
266 | (2) |
|
Interpreting cost-effectiveness `league tables' |
|
|
268 | (4) |
|
Transferring economic evaluation results from setting to setting |
|
|
272 | (12) |
|
Problems and potential for using economic evaluation in decision-making |
|
|
284 | (6) |
|
|
290 | (3) |
|
How to take matters further |
|
|
293 | (4) |
|
Economic evaluator's survival guide |
|
|
293 | (2) |
|
|
295 | (2) |
Author index |
|
297 | (2) |
Subject index |
|
299 | |